Search ⌘K
Tipsheet
An editorial reading of India’s listed companies.
Concalls

Concall Notes.

Short editorial briefs on Indian earnings calls. When management's guidance contradicts what they said last quarter, we lead with the contradiction — that is the news. Underlying transcripts and analysis are produced by Tijori Concall Monitor; we summarise and add editorial framing.

Where management changed its story

Calls where this quarter's guidance contradicts a prior call. Source: Tijori Concall Monitor's consistency check, summarised editorially.

  1. SPENCERS · Retail · 22 May 2026

    Spencer's Retail shifts goalposts on EBITDA breakeven

    Management pushed the FY26 offline break-even target to FY27, while revising the reason for Nature's Basket's ongoing inventory issues.

    Inconsistency In November 2025, management promised offline EBITDA breakeven by end-FY26. In May 2026, they pushed that goal to FY27 without explanation. Separately, they blamed Nature's Basket struggles on supplier terms in February, but pivoted to an inventory synchronization issue in May.

    Growth has returned to the topline, but shifting profit targets and changing internal diagnoses suggest the turnaround remains fragile.

  2. MAXHEALTH · Hospitals · 22 May 2026

    Max Healthcare revises oncology expectations as project timelines slip

    Management admits oncology revenue share will remain below historical peaks while deferring completion dates for major hospital projects in Gurgaon and Lucknow.

    Inconsistency Management previously stated oncology revenue would follow a historical upward trajectory. Now they expect it to stay at 21-22% rather than returning to 25-26%. The Gurgaon facility commissioning also moved from H1 FY27 to the end of the year.

    Max Healthcare is trading oncology-led margins for volume-heavy greenfield bets, but its recurring habit of missing project timelines remains a credibility risk.

Recent Concall Notes

  1. LXCHEM · Chemicals · 22 May 2026

    Laxmi Organic avoids FY27 revenue targets as logistics costs bite

    CEO Rajan Venkatesh signals that Middle East conflict logistics surcharges are structurally different from COVID-era spikes, clouding visibility for the company's Dahej expansion.

    Management is right to withhold guidance; with logistics costs doubling and spreads underperforming, a firm target would be reckless.

  2. PRIMECAB · Engineering & Capital Goods · 22 May 2026

    Prime Cable Inds. maps 45% annual growth to new capacity

    The company targets 45% revenue growth over two years as it transitions from low-voltage cables into higher-margin medium-voltage products.

    Prime Cable's growth math is sound, but its success rests entirely on thinning the government-heavy receivables backlog.